Skip to main content
Clinical Trials/KCT0007196
KCT0007196
Recruiting
未知

Effect of blood pressure variability and nocturnal hypertension on hypertension-mediated organ damage and cardiovascular disease in elderly patients with hypertension

Chungbuk National University Hospital0 sites1,300 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the circulatory system
Sponsor
Chungbuk National University Hospital
Enrollment
1300
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients aged 65 or older with hypertension and enrolled in the target blood pressure study (HOWOLD\-BP trial, 2018\-09\-015\) among elderly hypertension subjects who voluntarily participated in this clinical trial and agreed to participate in the study.

Exclusion Criteria

  • It is the same as the exclusion criteria of the study on prognosis analysis according to target blood pressure when treating hypertension in elderly hypertension subjects (HOWOLD\-BP trial, 2018\-09\-015\). Patients who meet any of the following criteria cannot participate in this clinical trial.
  • 1\) Subjects with all suspected history of secondary hypertension, such as aortic stenosis, hyperaldosterone, renal stenosis, cushing disease, chromium\-friendly cytoma, and polycystic nephrotic disease, and all suspected of secondary hypertension.
  • 2\) Resistant hypertension subjects whose blood pressure is controlled to less than 140/90 mmHg using three or more antithrombotic drugs, including diuretics, or four or more antithrombotic drugs including diuretics, with blood pressure controlled to less than 140/90 mmHg.
  • 3\) Subjects with orthostatic hypotension (One minute standing SBP \< 110 mmHg) accompanied by symptoms at the time of screening
  • 4\) Subject to uncontrolled diabetes whose HbA1C value is defined to be 10% or higher at the time of screening.
  • 5\) Subject to chronic kidney disease with maintenance dialysis or estimated GFR 1515 mL/min/1\.73 m2
  • 6\) Subjects who have undergone acute coronary syndrome, heart surgery, and urgent percutaneous coronary intervention (PCI) within the last 3 months.
  • 7\) Subject to systolic heart failure with a left ventricular uvula rate of less than 40% in the past history.
  • 8\) Subjects with hypertrophic obstructive cardiomyopathy, aortic stenosis, severe valve disease, and hemodynamically significant congenital heart disease.
  • 9\) Subject to acute stroke diagnosed with stroke within the last 3 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials